Recently, Celastrol, a quinone methide triterpene from Tripterygium wilfordii , has been shown to exhibit anti-pancreatic cancer activity both in vitro and in vivo through the disruption of Cdc37/Hsp90 association and the subsequent degradation of Hsp90 client proteins [26]. Here, HSP90AA1 is linked to familial pancreatic carcinoma.